OVERVIEW

International Association for the Study of Lung Cancer (IASLC) 2020 World Conference on Lung Cancer is organized by International Association for the Study of Lung Cancer (IASLC) and will be held from Jan 28 - 31, 2021.

Goal & Purpose:
The IASLC WCLC 2020 is the world’s largest international gathering of clinicians, researchers, and scientists in the field of lung cancer and thoracic oncology. Bringing together lung cancer specialists from around the world and across disciplines, the meeting offers unique opportunities for collaboration, learning and sharing the latest developments in lung cancer and thoracic malignancy research, prevention, diagnosis, treatment and management. With 18 educational tracks and over 100 global experts as invited speakers, WCLC 2020 provides a robust, comprehensive scientific program encompassing cutting edge knowledge on subjects such as tumor biomarkers, clinical trials, targeted therapies, liquid biopsy, screening, immunotherapy, tobacco control and patient advocacy even in a virtual environment. Sessions include plenaries with live Q&A, expert lectures, panel discussions, oral abstracts and posters.

Learning Objectives:
At the conclusion of this activity, participants will be able to:
• Examine scientific advances in thoracic cancer including the pathogenesis, biology, and mechanisms of drug interactions that can be used to make evidence-based diagnosis and treatment decisions.
• Synthesize cutting edge research from clinical trials and translational studies conducted around the world to deepen knowledge within primary specialty area(s) and broaden knowledge of other specialties.
• Advocate for lung cancer prevention strategies including tobacco control, smoking cessation, reducing environmental risks, addressing the quality and value of healthcare, and implementing early screening.
• Apply evidence-based recommendations and clinical practice guidelines to diagnose and manage patients.
• Collaborate on multidisciplinary teams to improve patient outcomes through patient-centered diagnostic, therapeutic and palliative care.
• Engage and empower patients to become active participants in their treatment.